Richard R. DeLuca - Nov 8, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
Stock symbol
MRK
Transactions as of
Nov 8, 2023
Transactions value $
-$4,602,668
Form type
4
Date filed
11/9/2023, 09:04 AM
Previous filing
May 4, 2023
Next filing
Jan 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Sale -$4.6M -43.8K -28.17% $105.03 112K Nov 8, 2023 Direct F1, F2
holding MRK Common Stock - 401(k) Plan 1.22K Nov 8, 2023 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.0000 to $105.0750, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F2 Holdings include shares acquired in dividend reinvestment transactions.
F3 Includes shares acquired and dividends earned through October 6, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.